Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery

被引:8
作者
Basu, Poulami
Qipshidze, Natia
Sen, Utpal
Givvimani, Srikanth
Munjal, Charu
Mishra, Paras K.
Tyagi, Suresh C.
机构
[1] Department of Physiology and Biophysics, University of Louisville, School of Medicine, Louisville, KY
关键词
CYSTATHIONINE BETA-SYNTHASE; ENDOTHELIAL PROGENITOR CELLS; RANDOMIZED CONTROLLED-TRIAL; INDUCED OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PLASMA HOMOCYSTEINE; DYSFUNCTION; MICE;
D O I
10.3109/13813455.2011.599844
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study we tested the hypothesis whether hyperhomocysteinemia, an elevated homocysteine level, induces venous phenotype in artery. To test our hypothesis, we employed wild type (WT) and cystathionine beta-synthase heterozygous (+/-) (CBS +/-) mice treatment with or without folic acid (FA). Aortic blood flow and velocity were significantly lower in CBS+/- mice compared to WT. Aortic lumen diameter was significantly decreased in CBS +/- mice, whereas FA treatment normalized it. Medial thickness and collagen were significantly increased in CBS +/- aorta, whereas elastin/collagen ratio was significantly decreased. Superoxide and gelatinase activity was significantly high in CBS +/- aorta vs WT. Western blot showed significant increase in MMP-2, -9,-12, TIMP-2 and decrease in TIMP-4 in aorta. RT-PCR revealed significant increase of vena cava marker EphB4, MMP-13 and TIMP-3 in aorta. We summarize that chronic HHcy causes vascular remodelling that transduces changes in vascular wall in a way that artery expresses vein phenotype.
引用
收藏
页码:270 / 282
页数:13
相关论文
共 60 条
[1]   Brothers and Sisters Molecular Insights Into Arterial-Venous Heterogeneity [J].
Aitsebaomo, Julius ;
Portbury, Andrea L. ;
Schisler, Jonathan C. ;
Patterson, Cam .
CIRCULATION RESEARCH, 2008, 103 (09) :929-939
[2]   Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors A Randomized Trial [J].
Armitage, Jane M. ;
Bowman, Louise ;
Clarke, Robert J. ;
Wallendszus, Karl ;
Bulbulia, Richard ;
Rahimi, Kazem ;
Haynes, Richard ;
Parish, Sarah ;
Sleight, Peter ;
Peto, Richard ;
Collins, Rory .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (24) :2486-2494
[3]   Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK [J].
Bao, Xiao-Mei ;
Wu, Chun-Fang ;
Lu, Guo-Ping .
ATHEROSCLEROSIS, 2010, 210 (01) :114-121
[4]  
Basu P, 2010, VASC HEALTH RISK MAN, V6, P215
[5]   Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives [J].
Beaudeux, JL ;
Giral, P ;
Bruckert, E ;
Foglietti, MJ ;
Chapman, MJ .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) :121-131
[6]  
Bhalodia YS, 2011, J NEPHROL, V00, P000
[7]   Metalloproteinases and plasminogen activators in vesset remodeling [J].
Bobik, A ;
Tkachuk, V .
CURRENT HYPERTENSION REPORTS, 2003, 5 (06) :466-472
[8]   Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway [J].
Bond, M ;
Murphy, G ;
Bennett, MR ;
Newby, AC ;
Baker, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13787-13795
[9]   MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix [J].
Chun, TH ;
Sabeh, F ;
Ota, I ;
Murphy, H ;
McDonagh, KT ;
Holmbeck, K ;
Birkedal-Hansen, H ;
Allen, ED ;
Weiss, SJ .
JOURNAL OF CELL BIOLOGY, 2004, 167 (04) :757-767
[10]   Murine models of hyperhomocysteinemia and their vascular phenotypes [J].
Dayal, Sanjana ;
Lentz, Steven R. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (09) :1596-1605